FDA Approves Budesonide Oral Suspension for Eosinophilic Esophagitis
Pharmacy Times
FEBRUARY 12, 2024
The FDA approval marks the first and only FDA-approved oral therapy for this patient population, and the drug is expected to be available by the end of February.
Let's personalize your content